The Danish multiple sclerosis treatment register
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
The Danish multiple sclerosis treatment register. / Magyari, Melinda; Koch-Henriksen, Nils; Sørensen, Per Soelberg.
I: Clinical Epidemiology, Bind 8, 25.10.2016, s. 549-552.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The Danish multiple sclerosis treatment register
AU - Magyari, Melinda
AU - Koch-Henriksen, Nils
AU - Sørensen, Per Soelberg
PY - 2016/10/25
Y1 - 2016/10/25
N2 - Aim of the database: The Danish Multiple Sclerosis Treatment Register (DMSTR) serves as a clinical quality register, enabling the health authorities to monitor the quality of the diseasemodifying treatment, and it is an important data source for epidemiological research. Study population: The DMSTR includes all patients with multiple sclerosis who had been treated with disease-modifying drugs since 1996. At present, more than 8,400 patients have been registered in this database. Data are continuously entered online into a central database from all sites in Denmark at start and at regular visits. Main variables: Include age, sex, onset year and year of the diagnosis, basic clinical information, and information about treatment, side effects, and relapses. Descriptive data: Notification is done at treatment start, and thereafter at every scheduled clinical visit 3 months after treatment start, and thereafter every 6 months. The longitudinally collected information about the disease activity and side effects made it possible to investigate the clinical efficacy and adverse events of different disease-modifying therapies. Conclusion: The database contributed to a certain harmonization of treatment procedures in Denmark and will continue to be a major factor in terms of quality in clinical praxis, research and monitoring of adverse events, and plays an important role in research.
AB - Aim of the database: The Danish Multiple Sclerosis Treatment Register (DMSTR) serves as a clinical quality register, enabling the health authorities to monitor the quality of the diseasemodifying treatment, and it is an important data source for epidemiological research. Study population: The DMSTR includes all patients with multiple sclerosis who had been treated with disease-modifying drugs since 1996. At present, more than 8,400 patients have been registered in this database. Data are continuously entered online into a central database from all sites in Denmark at start and at regular visits. Main variables: Include age, sex, onset year and year of the diagnosis, basic clinical information, and information about treatment, side effects, and relapses. Descriptive data: Notification is done at treatment start, and thereafter at every scheduled clinical visit 3 months after treatment start, and thereafter every 6 months. The longitudinally collected information about the disease activity and side effects made it possible to investigate the clinical efficacy and adverse events of different disease-modifying therapies. Conclusion: The database contributed to a certain harmonization of treatment procedures in Denmark and will continue to be a major factor in terms of quality in clinical praxis, research and monitoring of adverse events, and plays an important role in research.
KW - Disease modifying therapy
KW - Epidemiology
KW - Immunomodulatory treatment
KW - Multiple sclerosis
KW - Neutralizing antibodies
KW - Observational studies
KW - Registry research
U2 - 10.2147/CLEP.S99500
DO - 10.2147/CLEP.S99500
M3 - Review
C2 - 27822098
AN - SCOPUS:84995642192
VL - 8
SP - 549
EP - 552
JO - Clinical Epidemiology
JF - Clinical Epidemiology
SN - 1179-1349
ER -
ID: 179214827